| 16206603
|
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]. |
Ter Arkh |
2005 |
Skvortsov AA;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Mareev VIu;Belenkov IuN |
View
More |
| 16883264
|
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]. |
Kardiologiia |
2006 |
Skvortsov AA;Nasonova SN;Sychev AV;Orlova IaA;Baklanova NA;Masenko VP;Mareev VIu;Belenkov IuN |
View
More |
| 17076227
|
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]. |
Ter Arkh |
2006 |
Skvortsov AA;Mareev VIu;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Masenko VP;Belenkov IuN |
View
More |
| 17078211
|
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)]. |
Ter Arkh |
2006 |
Skvortsov AA;Mareev VIu;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Masenko VP;Belenkov IuN |
View
More |
| 30628901
|
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/ valsartan treatment: A case report. |
Turk Kardiyol Dern Ars |
2019 |
Turk UO;Alioglu E |
View
More |
